Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seladelpar and Cilofexor in Combination for Primary Biliary Cholangitis
NCT07841977Phase 2Recruiting
- Sponsor
- Gilead Sciences
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of seladelpar, cilofexor in primary biliary cholangitis (PBC), sponsored by Gilead Sciences. Started Oct 2026; status: recruiting.
02
Drugs
seladelparcilofexor
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT07841977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841977.